ALFA Finder| Revenue growth | 15.14% YoY for FY26. |
|---|---|
| Margins | Mature hospitals at 23.06%; Raipur hospital drag at -49.46%. |
| Demand visibility | Strong regional brand; medical tourism from Bangladesh recovering. |
| Management confidence | High; focus on asset productivity and clinical expansion. |
Growth
Revenue grew 15.1% YoY to ₹478.5 Cr; ARPOB increased to ₹39,243. Q4 revenue up 24.3% YoY.
Outlook
Targeting 1,000+ beds in 2 years; Jamshedpur 150-bed project underway for FY27. ROE/ROCE target ~25%.
Risks
New Raipur hospital impacted overall EBITDA margins (18.84% vs 22.1% in FY25). Dependency on Eastern India geography.
Earnings Call filed with BSE, NSE: GPTHEALTH. Summary written with AI assistance from the document.
GPT Healthcare Ltd: key numbers
- Share price
- ₹145.02
- Market cap
- ₹1,190 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 22.9×Sector 54.5×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Earnings Call Transcript: Key Takeaways
Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.
GPT Healthcare Results Update
GPT Healthcare filed a press release on unaudited Q2 and H1 FY27 results, reporting H1 total income of Rs 266.8 Cr and PAT of Rs 28.1 Cr. The release carries a P&L highlights table without the full SEBI results statement.
GPT Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
GPT Healthcare Dividend
GPT Healthcare's board declared an interim dividend of ₹1.00 per share for FY2026-27. Record date is November 12, 2026, with payment expected by December 4, 2026.
GPT Healthcare Q2 FY27 Results: Net Profit ₹15.4 Cr, Up 45.3% YoY
GPT Healthcare approved unaudited Q2 and half-year results, with H1 revenue of Rs 26,182.60 lakh. A 10% interim dividend was declared with a November 12 record date.
- Key figure
- Net profit ₹15.4 Cr · +45.3% YoY
GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.